Hester Bios

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE782E01017
  • NSEID: HESTERBIO
  • BSEID: 524669
INR
1,251.00
-67.95 (-5.15%)
BSENSE

Mar 30

BSE+NSE Vol: 7.96 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryHester Bios VS Pharmaceuticals & Biotechnology
 
1D
-5.15%
-2.22%
1W
-6.58%
-1.03%
1M
-18.83%
-10.33%
YTD
-21.42%
-15.57%
1Y
-0.23%
-7.06%
3Y
-20.79%
24.13%
5Y
-34.07%
43.5%
10Y
155.78%
183.94%
  • Stock Absolute Returns
  • India SENSEXAbsolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.53%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-20.65%
0%
-20.65%
6 Months
-33.9%
0%
-33.9%
1 Year
-0.23%
0.41%
0.18%
2 Years
-9.95%
0.82%
-9.13%
3 Years
-20.79%
1.16%
-19.63%
4 Years
-52.43%
1.19%
-51.24%
5 Years
-34.07%
1.89%
-32.18%

Latest dividend: 7 per share ex-dividend date: Aug-06-2025

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
Return Quartiles - by Industry stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
Return Quartiles - by Market Cap stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
stock-summaryRisk Adjusted Returns v/s India SENSEX
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available